Enhancing COVID-19 vaccination as a public programme in Indonesia

Evidence indicates that widespread vaccination with safe and effective COVID-19 vaccines represents the most viable strategy for controlling the pandemic. Implementing this approach as a public health programme offers a promising pathway for preventing future pandemics and managing infectious diseas...

Full description

Saved in:
Bibliographic Details
Main Authors: Rano K. Sinuraya, Auliya A. Suwantika, Maarten J. Postma
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Global Security: Health, Science and Policy
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/23779497.2025.2529166
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849423450239664128
author Rano K. Sinuraya
Auliya A. Suwantika
Maarten J. Postma
author_facet Rano K. Sinuraya
Auliya A. Suwantika
Maarten J. Postma
author_sort Rano K. Sinuraya
collection DOAJ
description Evidence indicates that widespread vaccination with safe and effective COVID-19 vaccines represents the most viable strategy for controlling the pandemic. Implementing this approach as a public health programme offers a promising pathway for preventing future pandemics and managing infectious disease outbreaks. In this article, we examine the integration of COVID-19 vaccination into Indonesia’s public health system, identifying key challenges and proposing strategies to enhance vaccine coverage. Our findings underscore the critical role of robust vaccination programmes, as highlighted by the COVID-19 pandemic, in strengthening Indonesia’s preparedness for infectious disease threats. Lessons learned from the COVID-19 vaccination campaign can inform prioritisation efforts for other vaccine-preventable diseases (VPDs). Policymakers, healthcare providers, and the public can reinforce Indonesia’s approach to VPDs by analysing the strategies, obstacles, and insights gained during the COVID-19 response. One key area for improvement is the enhancement of coordination and integration of vaccination efforts within the primary healthcare system. The pandemic revealed the urgent need for a cohesive and resilient public health infrastructure capable of effectively managing infectious diseases. Addressing systemic challenges – such as the absence of a centralised national vaccine policy authority – can streamline implementation and improve responsiveness. Looking forward, it is essential to incorporate COVID-19 vaccination into routine immunisation schedules and develop targeted strategies for broader demographic groups. Equally important is the continuous monitoring of vaccine safety. Establishing a national pharmacovigilance system to track, evaluate, and transparently report adverse events following immunisation (AEFI) is vital for sustaining public confidence and guiding evidence-based policy. Moreover, leveraging digital technologies, fostering community engagement, and ensuring equitable access are crucial to maintaining a sustainable, responsive, and resilient vaccination programme.
format Article
id doaj-art-76cee27781cf403090ca97abc4542f1b
institution Kabale University
issn 2377-9497
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Global Security: Health, Science and Policy
spelling doaj-art-76cee27781cf403090ca97abc4542f1b2025-08-20T03:30:35ZengTaylor & Francis GroupGlobal Security: Health, Science and Policy2377-94972025-12-0110110.1080/23779497.2025.2529166Enhancing COVID-19 vaccination as a public programme in IndonesiaRano K. Sinuraya0Auliya A. Suwantika1Maarten J. Postma2Unit of Global Health, Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, the NetherlandsDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, IndonesiaUnit of Global Health, Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, the NetherlandsEvidence indicates that widespread vaccination with safe and effective COVID-19 vaccines represents the most viable strategy for controlling the pandemic. Implementing this approach as a public health programme offers a promising pathway for preventing future pandemics and managing infectious disease outbreaks. In this article, we examine the integration of COVID-19 vaccination into Indonesia’s public health system, identifying key challenges and proposing strategies to enhance vaccine coverage. Our findings underscore the critical role of robust vaccination programmes, as highlighted by the COVID-19 pandemic, in strengthening Indonesia’s preparedness for infectious disease threats. Lessons learned from the COVID-19 vaccination campaign can inform prioritisation efforts for other vaccine-preventable diseases (VPDs). Policymakers, healthcare providers, and the public can reinforce Indonesia’s approach to VPDs by analysing the strategies, obstacles, and insights gained during the COVID-19 response. One key area for improvement is the enhancement of coordination and integration of vaccination efforts within the primary healthcare system. The pandemic revealed the urgent need for a cohesive and resilient public health infrastructure capable of effectively managing infectious diseases. Addressing systemic challenges – such as the absence of a centralised national vaccine policy authority – can streamline implementation and improve responsiveness. Looking forward, it is essential to incorporate COVID-19 vaccination into routine immunisation schedules and develop targeted strategies for broader demographic groups. Equally important is the continuous monitoring of vaccine safety. Establishing a national pharmacovigilance system to track, evaluate, and transparently report adverse events following immunisation (AEFI) is vital for sustaining public confidence and guiding evidence-based policy. Moreover, leveraging digital technologies, fostering community engagement, and ensuring equitable access are crucial to maintaining a sustainable, responsive, and resilient vaccination programme.https://www.tandfonline.com/doi/10.1080/23779497.2025.2529166COVID-19 vaccinationpublic healthvaccine hesitancyhealth policynational immunisation programpandemic
spellingShingle Rano K. Sinuraya
Auliya A. Suwantika
Maarten J. Postma
Enhancing COVID-19 vaccination as a public programme in Indonesia
Global Security: Health, Science and Policy
COVID-19 vaccination
public health
vaccine hesitancy
health policy
national immunisation program
pandemic
title Enhancing COVID-19 vaccination as a public programme in Indonesia
title_full Enhancing COVID-19 vaccination as a public programme in Indonesia
title_fullStr Enhancing COVID-19 vaccination as a public programme in Indonesia
title_full_unstemmed Enhancing COVID-19 vaccination as a public programme in Indonesia
title_short Enhancing COVID-19 vaccination as a public programme in Indonesia
title_sort enhancing covid 19 vaccination as a public programme in indonesia
topic COVID-19 vaccination
public health
vaccine hesitancy
health policy
national immunisation program
pandemic
url https://www.tandfonline.com/doi/10.1080/23779497.2025.2529166
work_keys_str_mv AT ranoksinuraya enhancingcovid19vaccinationasapublicprogrammeinindonesia
AT auliyaasuwantika enhancingcovid19vaccinationasapublicprogrammeinindonesia
AT maartenjpostma enhancingcovid19vaccinationasapublicprogrammeinindonesia